IBM Watson Health: Patient-level outcomes: Methodological considerations for retrospective data collected during a pandemic
8:0am - 9:0am
Learn how IBM Watson Health leaders and researchers recommend that you shift your real-world evidence generation strategy and methodologies to account for the effects of a global pandemic.
COVID-19 has led to significant changes in healthcare delivery and will subsequently impact how researchers use retrospective data to evaluate patient outcomes.
Join Liisa Palmer, PhD, Outcomes Research Portfolio Leader for IBM Watson Health Life Sciences, for a discussion of the impact of a pandemic on short- and long-term patient outcomes and implications for the use of real-world data for outcomes research moving forward.
Contact: Micaela Acomb
Contact Email: email@example.com